Now approved for use in Pediatrics
- Treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA).
- Treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.
Please click here for the full Prescribing information, including Boxed Warning regarding embryo-fetal toxicity, hypersensitivity reactions, and severe adverse reactions.
